Certolizumab pegol Completed Phase 3 Trials for Interstitial Cystitis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02497976Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis